Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.
|
April 21, 2013
|
April 21, 2013
|
April 17, 2013
|
April 15, 2013
|
|
February 12, 2013
|
February 12, 2013
|
February 12, 2013
|
February 8, 2013
|